Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to ...
A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...
Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...
It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.
Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.
In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 ...
NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.
Medical Xpress on MSN10d
People Who Are Immunocompromised May Not Produce Enough Protective Antibodies Against RSV After VaccinationThe U.S. Centers for Disease Control and Prevention (CDC) currently recommends that everyone 75 and older receive a single ...
Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...
NIH researchers identified MAD21-101, a novel antibody targeting a previously unexplored epitope on the malaria parasite.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback